{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:31:41Z","timestamp":1790289101593,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00280-019-03968-2","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T17:02:51Z","timestamp":1570208571000},"page":"1333-1338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cisplatin ototoxicity in children: risk factors and its relationship with polymorphisms of DNA repair genes ERCC1, ERCC2, and XRCC1"],"prefix":"10.1007","volume":"84","author":[{"given":"Caner","family":"Turan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1669-4321","authenticated-orcid":false,"given":"Mehmet","family":"Kantar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7a\u011fda\u015f","family":"Aktan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buket","family":"Kosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Orman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Bilgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayfun","family":"Kirazl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,4]]},"reference":[{"issue":"19","key":"3968_CR1","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1200\/JCO.2011.39.1110","volume":"30","author":"PR Brock","year":"2012","unstructured":"Brock PR, Knight KR, Freyer DR, Campbell KC, Steyger PS, Blakley BW et al (2012) Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new international society of pediatric oncology boston ototoxicity scale. J Clin Oncol 30(19):2408\u20132417. \n                    https:\/\/doi.org\/10.1200\/JCO.2011.39.1110","journal-title":"J Clin Oncol"},{"issue":"1","key":"3968_CR2","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1038\/s41598-019-40138-z","volume":"9","author":"E Tserga","year":"2019","unstructured":"Tserga E, Nandwani T, Edvall NK, Bulla J, Patel P, Canlon B et al (2019) The genetic vulnerability to cisplatin ototoxicity: a systematic review. Sci Rep 9(1):3455. \n                    https:\/\/doi.org\/10.1038\/s41598-019-40138-z","journal-title":"Sci Rep"},{"issue":"11","key":"3968_CR3","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/pbc.25123","volume":"61","author":"E Peleva","year":"2014","unstructured":"Peleva E, Emami N, Alzahrani M, Bezdjian A, Gurberg J, Carret AS et al (2014) Incidence of platinum-induced ototoxicity in pediatric patients in Quebec. Pediatr Blood Cancer 61(11):2012\u20132017","journal-title":"Pediatr Blood Cancer"},{"key":"3968_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010181.pub2","author":"JW van As","year":"2016","unstructured":"van As JW, van den Berg H, van Dalen EC (2016) Platinum-induced hearing loss after treatment for childhood cancer. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD010181.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"3968_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/cncr.22004","volume":"107","author":"BH Kushner","year":"2006","unstructured":"Kushner BH, Budnick A, Kramer K, Modak S, Cheung NK (2006) Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma. Cancer 107:417\u2013422","journal-title":"Cancer"},{"issue":"6","key":"3968_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1200\/JCO.2013.51.2038","volume":"32","author":"W Landier","year":"2014","unstructured":"Landier W, Knight K, Wong FL, Lee J, Thomas O, Kim H et al (2014) Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales\u2014a report from the children\u2019s oncology group. J Clin Oncol 32(6):527\u2013534","journal-title":"J Clin Oncol"},{"issue":"2","key":"3968_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/clpt.2013.121","volume":"94","author":"JJ Yang","year":"2013","unstructured":"Yang JJ, Lim JY, Huang J, Bass J, Wu J, Wang C et al (2013) The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer. Clin Pharmacol Ther 94(2):252\u2013259","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"3968_CR8","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.ijrobp.2009.09.031","volume":"78","author":"AC Paulino","year":"2010","unstructured":"Paulino AC, Lobo M, Teh BS, Okcu MF, South M, Butler EB et al (2010) Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys 78(5):1445\u20131450","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"3968_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/tpj.2009.19","volume":"9","author":"D Caronia","year":"2009","unstructured":"Caronia D, Pati\u00f1o-Garc\u00eda A, Milne RL, Zalacain-D\u00edez M, Pita G, Alonso MR et al (2009) Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. Pharmacogenomics J 9(5):347\u2013353","journal-title":"Pharmacogenomics J"},{"key":"3968_CR10","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1200\/JCO.2006.10.077","volume":"24","author":"JM Rademaker-Lakhai","year":"2006","unstructured":"Rademaker-Lakhai JM, Crul M, Zuur L, Baas P, Beijnen JH, Simis YJ et al (2006) Relationship between cisplatin administration and the development of ototoxicity. J Clin Oncol 24:918\u2013924","journal-title":"J Clin Oncol"},{"issue":"13","key":"3968_CR11","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1158\/1078-0432.CCR-16-2809","volume":"23","author":"HE Wheeler","year":"2017","unstructured":"Wheeler HE, Gamazon ER, Frisina RD, Perez-Cervantes C, El Charif O, Mapes B et al (2017) Variants in WFS1 and other mendelian deafness genes are associated with cisplatin-associated ototoxicity. Clin Cancer Res 23(13):3325\u20133333. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-2809","journal-title":"Clin Cancer Res"},{"issue":"11","key":"3968_CR12","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/cam4.516","volume":"4","author":"AL Brown","year":"2015","unstructured":"Brown AL, Lupo PJ, Okcu MF, Lau CC, Rednam S, Scheurer ME (2015) SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma. Cancer Med 4(11):1679\u20131686. \n                    https:\/\/doi.org\/10.1002\/cam4.516","journal-title":"Cancer Med"},{"issue":"5","key":"3968_CR13","doi-asserted-by":"publisher","first-page":"26931","DOI":"10.1002\/pbc.26931","volume":"65","author":"SE Soliman","year":"2018","unstructured":"Soliman SE, D\u2019Silva CN, Dimaras H, Dzneladze I, Chan H, Gallie BL (2018) Clinical and genetic associations for carboplatin-related ototoxicity in children treated for retinoblastoma: A retrospective noncomparative single-institute experience. Pediatr Blood Cancer 65(5):26931 10.1002\/pbc.26931","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"3968_CR14","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1097\/MPH.0b013e3182707fc5","volume":"35","author":"W Choeyprasert","year":"2013","unstructured":"Choeyprasert W, Sawangpanich R, Lertsukprasert K, Udomsubpayakul U, Songdej D, Unurathapan U et al (2013) Cisplatin-induced ototoxicity in pediatric solid tumors: the role of glutathione S-transferases and megalin genetic polymorphisms. J Pediatr Hematol Oncol 35(4):e138\u2013e143. \n                    https:\/\/doi.org\/10.1097\/MPH.0b013e3182707fc5","journal-title":"J Pediatr Hematol Oncol"},{"key":"3968_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/mpo.2950190415","volume":"19","author":"PR Brock","year":"1991","unstructured":"Brock PR, Bellman SC, Yeomans EC, Pinkerton CR, Pritchard J et al (1991) Cisplatin ototoxicity in children: a practical grading system. Med Pediatr Oncol 19:295\u2013300","journal-title":"Med Pediatr Oncol"},{"issue":"34","key":"3968_CR16","doi-asserted-by":"publisher","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","volume":"23","author":"KR Knight","year":"2005","unstructured":"Knight KR, Kraemer DF, Neuwelt EA (2005) Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol 23(34):8588\u20138596","journal-title":"J Clin Oncol"},{"key":"3968_CR17","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1200\/JCO.2009.24.4228","volume":"28","author":"KW Chang","year":"2010","unstructured":"Chang KW, Chinosomvatana N (2010) Practical grading system for evaluating cisplatin ototoxicity in children. J Clin Oncol 28:1788\u20131795","journal-title":"J Clin Oncol"},{"issue":"10","key":"3968_CR18","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1200\/JCO.2011.36.9744","volume":"30","author":"I Qaddoumi","year":"2012","unstructured":"Qaddoumi I, Bass JK, Wu J, Billups CA, Wozniak AW, Merchant TE et al (2012) Carboplatin-associated ototoxicity in children with retinoblastoma. J Clin Oncol 30(10):1034\u20131041","journal-title":"J Clin Oncol"},{"issue":"12","key":"3968_CR19","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/ng.478","volume":"41","author":"CJ Ross","year":"2009","unstructured":"Ross CJ, Katzov-Eckert H, Dub\u00e9 MP, Brooks B, Rassekh SR, Barhdadi A et al (2009) Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nat Genet 41(12):1345\u20131349. \n                    https:\/\/doi.org\/10.1038\/ng.478","journal-title":"Nat Genet"},{"issue":"12","key":"3968_CR20","doi-asserted-by":"publisher","first-page":"e115869","DOI":"10.1371\/journal.pone.0115869","volume":"9","author":"MM Hagleitner","year":"2014","unstructured":"Hagleitner MM, Coenen MJ, Patino-Garcia A, de Bont ES, Gonzalez-Neira A, Vos HI et al (2014) Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts. PLoS One 9(12):e115869. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0115869","journal-title":"PLoS One"},{"issue":"4","key":"3968_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.17116\/otorino201883460","volume":"83","author":"OL Mironovich","year":"2018","unstructured":"Mironovich OL, Bliznetz EA, Garbaruk ES, Belogurova MB, Subora NV, Varfolomeeva SR et al (2018) The analysis of the association of the polymorphic variants of the TPMT, COMT, and ABCC3 genes with the development of hearing disorders induced by the cisplatin treatment. Vestn Otorinolaringol 83(4):60\u201366. \n                    https:\/\/doi.org\/10.17116\/otorino201883460","journal-title":"Vestn Otorinolaringol"},{"issue":"6","key":"3968_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/FPC.0000000000000281","volume":"27","author":"S Thiesen","year":"2017","unstructured":"Thiesen S, Yin P, Jorgensen AL, Zhang JE, Manzo V, McEvoy L et al (2017) TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity. Pharmacogenet Genomics 27(6):213\u2013222","journal-title":"Pharmacogenet Genomics"},{"key":"3968_CR23","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1158\/1078-0432.CCR-04-0247","volume":"10","author":"W Zhou","year":"2004","unstructured":"Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC et al (2004) Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 10:4939\u20134943","journal-title":"Clin Cancer Res"},{"key":"3968_CR24","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1158\/1078-0432.CCR-04-1953","volume":"15","author":"R Suk","year":"2005","unstructured":"Suk R, Gurubhagavatula S, Park S, Zhou W, Su L, Lynch TJ et al (2005) Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients. Clin Cancer Res 15:1534\u20131538","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3968_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12881-018-0627-4","volume":"19","author":"H Obiedat","year":"2018","unstructured":"Obiedat H, Alrabadi N, Sultan E, Al Shatti M, Zihlif M (2018) The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients. BMC Med Genet 19(1):112","journal-title":"BMC Med Genet"},{"key":"3968_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.lungcan.2008.02.019","volume":"62","author":"Z Wang","year":"2008","unstructured":"Wang Z, Xu B, Lin D, Tan W, Leaw S, Hong X et al (2008) XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population. Lung Cancer 62:99\u2013104. \n                    https:\/\/doi.org\/10.1016\/j.lungcan.2008.02.019","journal-title":"Lung Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03968-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-019-03968-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03968-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T23:44:48Z","timestamp":1601682288000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-019-03968-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,4]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3968"],"URL":"https:\/\/doi.org\/10.1007\/s00280-019-03968-2","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,4]]},"assertion":[{"value":"9 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author(s) declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}